These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


496 related items for PubMed ID: 26247089

  • 1.
    Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Feingold KR.
    ; 2000. PubMed ID: 26247089
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A, Arranz M, Alvarez JJ, Perales J, Villar J, Herrera E, Lasunción MA.
    Clin Chim Acta; 1996 Apr 30; 248(2):157-74. PubMed ID: 8740580
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
    Musliner TA, Long MD, Forte TM, Nichols AV, Gong EL, Blanche PJ, Krauss RM.
    J Lipid Res; 1991 Jun 30; 32(6):917-33. PubMed ID: 1940624
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 30; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 8. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ, Breckenridge WC.
    Atherosclerosis; 1995 Dec 30; 118(2):193-212. PubMed ID: 8770314
    [Abstract] [Full Text] [Related]

  • 9. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.
    Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G.
    Biochem Soc Trans; 2003 Oct 30; 31(Pt 5):1070-4. PubMed ID: 14505482
    [Abstract] [Full Text] [Related]

  • 10. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J, Karpe F, Milne RW, Hamsten A.
    J Lipid Res; 1998 Jul 30; 39(7):1412-20. PubMed ID: 9684744
    [Abstract] [Full Text] [Related]

  • 11. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ, Breckenridge WC.
    Biochim Biophys Acta; 1996 Oct 18; 1303(3):222-32. PubMed ID: 8908157
    [Abstract] [Full Text] [Related]

  • 12. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
    Himber J, Missano B, Rudling M, Hennes U, Kempen HJ.
    J Lipid Res; 1995 Jul 18; 36(7):1567-85. PubMed ID: 7595080
    [Abstract] [Full Text] [Related]

  • 13. Hepatic lipase deficiency.
    Connelly PW, Hegele RA.
    Crit Rev Clin Lab Sci; 1998 Dec 18; 35(6):547-72. PubMed ID: 9885775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system.
    Eisenberg S.
    Klin Wochenschr; 1983 Feb 01; 61(3):119-32. PubMed ID: 6843039
    [Abstract] [Full Text] [Related]

  • 17. [Lipoprotein metabolism].
    Corvilain B.
    Rev Med Brux; 1997 Feb 01; 18(1):3-9. PubMed ID: 9132915
    [Abstract] [Full Text] [Related]

  • 18. Anomalous lipoproteins in obese Zucker rats.
    Blay M, Peinado-Onsurbe J, Julve J, Rodríguez V, Fernández-López JA, Remesar X, Alemany M.
    Diabetes Obes Metab; 2001 Aug 01; 3(4):259-70. PubMed ID: 11520306
    [Abstract] [Full Text] [Related]

  • 19. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.
    Craig WY, Cooper AD.
    J Lipid Res; 1988 Mar 01; 29(3):299-308. PubMed ID: 2837527
    [Abstract] [Full Text] [Related]

  • 20. Recent advances in physiological lipoprotein metabolism.
    Ramasamy I.
    Clin Chem Lab Med; 2014 Dec 01; 52(12):1695-727. PubMed ID: 23940067
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.